Skip to main content
Equibles
NAGE logo

NAGE · Niagen Bioscience, Inc. · Metrics

Track NAGE — free

Use NAGE with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research NAGE.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$2.50 +0.06 (+2.46%) At close · Oct 27 Q2 2026 earnings call transcript
Russell 2000 member Rebalance outlook locked
Market Cap
$193.07M
Shares
79.13M
Volume · Oct 27 473.48K Avg daily vol (3M) 546.87K

NAGE metrics

86 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$2.50
Market cap
$193.07M

Price action

20 metrics
Price change (1W)
-0.4%
Price change (30D)
-16.1%
Price change (3M)
-24.0%
Price change (6M)
-48.3%
Price change (YTD)
-60.7%
Price change (1Y)
-67.1%
Trailing year
Price change (5Y)
-59.2%
52-week high
$7.60
52-week low
$2.43
Change from 52-week high
-67.1%
Change from 52-week low
+2.9%
Annualized volatility
46.7%
Annualized volatility (3M)
45.8%
Beta
1.3
RSI (14D)
37.0
Price vs SMA 50
-13.8%
Price vs SMA 200
-37.1%
Avg volume (3M)
546,867
Relative volume
0.9
Average dollar volume
$1.62M

Company

3 metrics
Sector
Consumer Defensive
Industry
Packaged Foods
Shares outstanding
79.13M

Valuation

12 metrics
P / E (TTM)
13.9
Trailing earnings · reciprocal yield 7.2%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
1.5×
reciprocal yield 66.9%
P / book
2.3
reciprocal yield 42.7%
FCF yield
—
TTM · current market cap
Buyback yield
2.8%
P / FCF
—
P / operating cash flow
32.5
reciprocal yield 3.1%
Earnings yield
8.3%

Historical valuation

8 metrics
P / E historical average (3Y)
73.1×
reciprocal yield 1.4%
P / E historical average (5Y)
73.1×
reciprocal yield 1.4%
EV / revenue historical average (3Y)
8.0×
reciprocal yield 12.5%
EV / revenue historical average (5Y)
8.0×
reciprocal yield 12.5%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
2.8%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-11-04
Last earnings
2026-08-04

Profitability

9 metrics
Gross margin
64.2%
Operating margin
8.2%
Trailing 12 months
Net margin
12.4%
Gross profit (TTM)
$82.92M
Operating profit (TTM)
$10.60M
Net income (TTM)
$15.99M
Trailing 12 months
Diluted EPS (TTM)
$0.18
FCF margin
—
Effective tax rate
6.1%

Per share

11 metrics
Revenue per diluted share (TTM)
$1.52
Gross profit per diluted share (TTM)
$0.98
Operating profit per diluted share (TTM)
$0.12
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$0.19
Operating cash flow per diluted share (TTM)
$0.07
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
$0.08
Stock compensation per diluted share (TTM)
$0.08
Book value per share
$0.96

Growth

11 metrics
Revenue growth YoY
-4.3%
Year over year
Net income growth YoY
-73.3%
Revenue (TTM)
$129.08M
Trailing 12 months
EPS growth YoY
-75.0%
Shares change YoY
-4.3%
Year over year · fewer shares
Revenue CAGR (3Y)
+21.6%
Revenue CAGR (5Y)
+16.9%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
19.4%
Return on assets
15.0%
Debt / equity
—
Current ratio
6.5
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
5.1
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$66.74M
Total assets
$106.59M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$5.95M
Capital expenditures (TTM)
$427,000
R&D (TTM)
$6.50M
SG&A (TTM)
—
Stock compensation (TTM)
$6.94M
R&D / revenue
5.0%
Stock compensation / revenue
5.4%

Ownership (13F)

9 metrics
13F filers
140
13F filer change QoQ
-5
Institutional ownership
40.6%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
15.4%
Private-fund adviser ownership
15.2%
Active holders' share change QoQ
-21.4%
Holder tenure
11.4
Price vs estimated holder cost
-47.5%

Ownership (registered funds)

1 metrics
Index-fund ownership
10.2%

Short interest

3 metrics
Short interest
5.3%
Latest settlement · 6.2 days to cover
Days to cover
6.2d
Short-squeeze score
56 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1386570 CUSIP 171077407 13F (30d) 17 filings 16 filers Visit website Investor relations